Early Access — free while we kick the tires
EdgarHawk

Bhaskar Panigrahi

Chief Executive Officer

Director Officer

Latest: CEO buying · June 2026

6 filings analyzed · 1 company · Latest 2026-06-23

Companies

Company Buys Sells Direction
ConnectM Technology Solutions, Inc. CNTM 9 0 Net buying

Activity

June 2026
Buy
3,359 shares
$23,143
Significance 5/10

CNTM CEO Panigrahi makes 2 open-market buys totaling 3,359 shares for $23,143.02 at blended avg $6.89, vs current price $8.50.

Bhaskar Panigrahi, Chief Executive Officer of ConnectM Technology Solutions, Inc. (CNTM), filed two separate purchases totaling 3,359 shares for $23,143.02, executed at $6.78 and $6.96 respectively, bringing his post-transaction holdings to 150,826 shares. The stock is currently trading at $8.50, up +46.6% over the past 30 days but still -50.4% from its 52-week high, situating these purchases in a period of sharp recent recovery. His prior trades at CNTM show a highly uneven pattern: the two buys in November 2025 produced 90-day returns of +3684.3% and +4028.4%, while the three buys in September 2024 each saw 90-day returns of approximately -99.9% or worse, yielding a same-ticker 90-day win rate of only 2 of 5 prior trades. With the company reporting quarterly net income of $-6,945,745.00 against revenue of $8,172,553.00, the fundamental backdrop remains challenging despite +58.2% annual revenue growth.

December 2025
Buy
297,400 shares
$67,478
Significance 3/10

CNTM insider Bhaskar Panigrahi purchases 297,400 shares for $67,478.00 across 2 transactions; 0 of 5 prior same-ticker buys showed 90-day gains.

Panigrahi acquired 297,400 shares (297.4K shares) in two separate purchases on 2025-11-28 at blended average price $0.23, raising his holdings to 4,718,953 shares (4.72M shares). This follows a consistent pattern: all 5 prior buys at CNTM were ill-timed at the 90-day mark, with returns of -99.9% to -100.0%, and his cross-ticker track record across 5 prior buys shows a 0% 90-day win rate. The company's fundamentals remain challenged—it reported a net loss of $1,145,571.00 ($-1.1M) in the latest quarter and was unprofitable over its most recent full fiscal year. While annual revenue grew 13.4%, the persistent pattern of losses and the insider's prior unsuccessful buy timing at this ticker signal caution rather than conviction.

September 2024
Buy
30,000 shares
$1,006,380,000
Significance 6/10

Panigrahi Bhaskar bought 30,000 shares of CNTM at $33,546.00 on 2024-09-12; stock down 55.0% from 52-week high despite recent 14.3% bounce.

Panigrahi purchased 30,000 shares on 2024-09-12, extending a rapid sequence of four consecutive buys at CNTM within two weeks (2024-08-29 through 2024-09-12). His holdings grew 0.7% to 4,206,043 shares, confirming continued accumulation. The transaction occurred at $33,546.00 per share against a current price of $35.84, placing the stock -55.0% below its 52-week high of $79.68 yet +14.3% above its 30-day low. The company reported net income of $1,413,237.00 but was unprofitable over its most recent full fiscal year, creating a disconnect between near-term profitability and underlying performance. The combination of sustained purchasing at depressed valuation levels, repeated buy clustering, and deteriorated fundamentals warrants monitoring of whether recent share accumulation reflects new information or a pattern inconsistent with prior outcomes.

Buy
68,944 shares
$2,829,240,648
Significance 5/10

Panigrahi acquired 68,944 shares (69K) for $2.8B at blended avg $41,036.79; stock now $34.88, down 56.2% from 52-week high.

Panigrahi Bhaskar executed 2 separate purchases totaling 68,944 shares for $2,829,240,648.00 on consecutive trading days (September 6 and 11, 2024), increasing holdings to 4,176,043 shares (+1.7%). The transaction prices (averaging $41,036.79) substantially exceed the current market price of $34.88, representing an immediate paper loss on the acquired shares. The stock has declined 22.7% over the prior 30 days and sits 56.2% below its 52-week high of $79.68, suggesting significant downward price momentum at the time of purchase. The company reported negative full-year net income, and his prior open-market purchases at this ticker (August 29, September 4, and September 12) remain within outcome-measurement windows, with no established pattern of well-timed accumulation at CNTM to date.

Buy
65,274 shares
$3,749,403,834
Significance 7/10

Panigrahi Bhaskar bought 65,274 shares of CNTM for $3.7B on 2024-09-04, holding 4.11M shares post-trade as stock trades -53.4% from 52-week high.

Panigrahi Bhaskar acquired 65,274 shares at $57,441.00 per share on 2024-09-04, representing a purchase during a significant drawdown: the stock currently trades at $37.12, down 53.4% from its 52-week high of $79.68. The transaction brings his holdings to 4.11M shares (+1.6% net increase from prior position of 4.04M shares). This marks his third consecutive purchase at CNTM within 6 days—buys on 2024-08-29, 2024-09-04, and 2024-09-06—establishing a repeated buying pattern over a narrow window. The company remains unprofitable (full-year net income was negative) and has a market cap of $785.6M against this transaction's stated value of $3.7B, warranting close examination of the transaction's structural details and pricing methodology.

Buy
73,680 shares
$4,798,188,960
Significance 3/10

Bhaskar Panigrahi buys 73,680 shares of CNTM at $65,122.00 (Aug 29); stock now -61.8% from 52-week high.

Panigrahi purchased 73,680 shares at $65,122.00 on 2024-08-29, increasing his holdings from 3,968,145 to 4,041,825 shares (+1.9%). The purchase occurred near the upper end of the 52-week range ($22.75–$79.68) and the stock has since declined to $30.40, down 61.8% from the 52-week high. The company reported a net loss over its most recent full fiscal year, yet this represents only his second open-market purchase across all tickers in his track record, providing limited historical context for assessing his pattern of timing. With no measurable 90-day outcome yet available for his prior CNTM transaction (2024-09-04 buy) and the stock's substantial post-purchase decline, this transaction merits monitoring as new quarterly results and operational updates emerge.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access